175 related articles for article (PubMed ID: 14586070)
1. Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands: an immunohistochemical study.
Khan A; Tischler AS; Patwardhan NA; DeLellis RA
Endocr Pathol; 2003; 14(3):249-55. PubMed ID: 14586070
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin and calcitonin gene-related peptide mRNA detection in a population of hyperplastic parathyroid cells also expressing chromogranin B.
Schmid KW; Morgan JM; Baumert M; Fischer-Colbrie R; Böcker W; Jasani B
Lab Invest; 1995 Jul; 73(1):90-5. PubMed ID: 7603045
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.
Schmid KW; Hittmair A; Ladurner D; Sandbichler P; Gasser R; Tötsch M
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):295-9. PubMed ID: 2024450
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
Tanaka R; Umemura S; Kakuta T; Fujisaki T; Sakai H; Saitoh A; Osamura RY
Pathol Res Pract; 2003; 199(2):93-9. PubMed ID: 12747471
[TBL] [Abstract][Full Text] [Related]
5. A study of parathyroid hyperplasia in chronic renal failure.
Yong JL; Vrga L; Warren BA
Pathology; 1994 Apr; 26(2):99-109. PubMed ID: 8090603
[TBL] [Abstract][Full Text] [Related]
6. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
7. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity.
Loda M; Lipman J; Cukor B; Bur M; Kwan P; DeLellis RA
Hum Pathol; 1994 Oct; 25(10):1050-6. PubMed ID: 7927309
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal polypeptide-, neurotensin-, substance P-, gastrin-releasing peptide-, calcitonin-, calcitonin gene related peptide-, and somatostatin-like immunoreactivities in human parathyroid glands.
Weber CJ; O'Dorisio TM; Howe B; D'Agati V; Ward L; Russell J; Feind CR
Surgery; 1991 Dec; 110(6):1078-85. PubMed ID: 1720902
[TBL] [Abstract][Full Text] [Related]
9. Cellular expression and specific intragranular localization of chromogranin A, chromogranin B, and synaptophysin during ontogeny of pancreatic islet cells: an ultrastructural study.
Lukinius A; Stridsberg M; Wilander E
Pancreas; 2003 Jul; 27(1):38-46. PubMed ID: 12826904
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of cell cycle regulators, Fhit protein and apoptotic cells in parathyroid lesions.
Thomopoulou GE; Tseleni-Balafouta S; Lazaris AC; Koutselini H; Kavantzas N; Davaris PS
Eur J Endocrinol; 2003 Jan; 148(1):81-7. PubMed ID: 12534361
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid.
Schmid KW; Kirchmair R; Ladurner D; Fischer-Colbrie R; Böcker W
Histopathology; 1992 Sep; 21(3):225-32. PubMed ID: 1356907
[TBL] [Abstract][Full Text] [Related]
12. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas.
Riva C; Leutner M; Capella C; Usellini L; la Rosa S; Brianza MR; Buffa R
Zentralbl Pathol; 1993 Jun; 139(2):165-70. PubMed ID: 8396420
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of GATA-3 in cytological identification of parathyroid tissues.
Takada N; Hirokawa M; Suzuki A; Higuchi M; Kuma S; Miyauchi A
Endocr J; 2016 Jul; 63(7):621-6. PubMed ID: 27097544
[TBL] [Abstract][Full Text] [Related]
14. Storage and degradation of secretory proteins in adenomatous and secondary hyperplastic parathyroid cells. An immunoelectron microscope study.
Berger G; Berger F; Billard F; Danowski J; Vauzelle JL
Virchows Arch A Pathol Anat Histopathol; 1989; 415(4):305-16. PubMed ID: 2505443
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of Insulin-like growth factor-1, Transforming growth factor-beta1, and Vascular endothelial growth factor in parathyroid adenoma and hyperplasia.
Sayar H; Sahin M; Dogan PO; Karabulut S; Seringec N; Oguz A
Indian J Pathol Microbiol; 2014; 57(4):549-52. PubMed ID: 25308005
[TBL] [Abstract][Full Text] [Related]
16. Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidism.
Levine MA; Dempsey MA; Helman LJ; Ahn TG
J Clin Endocrinol Metab; 1990 Jun; 70(6):1668-73. PubMed ID: 2347900
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonic appearance of adenomatous and hyperplastic parathyroid glands.
Rastad J; Fransson A; Lindgren PG; Johansson H; Ljunghall S; Malmaeus J; Akerström G
Acta Radiol Diagn (Stockh); 1984; 25(6):471-5. PubMed ID: 6151782
[TBL] [Abstract][Full Text] [Related]
18. P53 as a marker of differentiation between hyperplastic and adenomatous parathyroids.
Ricci F; Mingazzini PL; Sebastiani V; D'Erasmo E; Letizia C; De Toma G; Alò PL
Ann Diagn Pathol; 2002 Aug; 6(4):229-35. PubMed ID: 12170454
[TBL] [Abstract][Full Text] [Related]
19. Nuclear DNA-content of parathyroid cells in adenomas, hyperplastic and normal glands.
Bengtsson A; Grimelius L; Johansson H; Pontén J
Acta Pathol Microbiol Scand A; 1977 Jul; 85(4):455-60. PubMed ID: 70956
[TBL] [Abstract][Full Text] [Related]
20. The role of hyperplasia in multiple parathyroid adenomas.
Larian B; Alavi S; Roesler J; Namazie A; Blackwell K; Calcaterra TC; Wang MB
Head Neck; 2001 Feb; 23(2):134-9. PubMed ID: 11303630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
